Agilon Health (AGL)
(Delayed Data from NYSE)
$3.87 USD
-0.12 (-3.01%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $3.86 -0.01 (-0.26%) 4:52 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Balance Sheet
Fiscal Year End for Agilon Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 495 | 920 | 1,055 | 135 | 139 |
Receivables | 942 | 498 | 293 | 145 | 93 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 43 | 34 | 19 | 14 | 13 |
Total Current Assets | 1,480 | 1,451 | 1,367 | 294 | 246 |
Net Property & Equipment | 28 | 20 | 9 | 6 | 7 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 4 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 88 | 109 | 97 | 102 | 113 |
Deposits & Other Assets | 145 | 117 | 113 | 44 | 33 |
Total Assets | 1,741 | 1,697 | 1,586 | 446 | 403 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 233 | 183 | 113 | 97 | 68 |
Current Portion Long-Term Debt | 6 | 5 | 5 | 3 | 3 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 738 | 347 | 239 | 167 | 129 |
Total Current Liabilities | 977 | 535 | 357 | 267 | 200 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 32 | 38 | 43 | 65 | 67 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 70 | 83 | 94 | 400 | 368 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,080 | 657 | 495 | 731 | 635 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 4 | 4 | 4 | 2 | 2 |
Capital Surplus | 1,987 | 2,107 | 2,046 | 264 | 257 |
Retained Earnings | -1,327 | -1,064 | -958 | -551 | -491 |
Other Equity | -3 | -6 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 661 | 1,041 | 1,092 | -285 | -232 |
Total Liabilities & Shareholder's Equity | 1,741 | 1,697 | 1,586 | 446 | 403 |
Total Common Equity | 661 | 1,041 | 1,092 | -285 | -232 |
Shares Outstanding | 406.00 | 411.80 | 393.60 | NA | NA |
Book Value Per Share | 1.63 | 2.53 | 2.77 | 0.00 | 0.00 |
Fiscal Year End for Agilon Health, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 408 | 426 | 495 | 574 | 590 |
Receivables | 1,437 | 1,571 | 942 | 1,346 | 1,417 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 39 | 40 | 43 | 37 | 38 |
Total Current Assets | 1,884 | 2,037 | 1,480 | 1,957 | 2,045 |
Net Property & Equipment | 28 | 28 | 28 | 26 | 24 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 99 | 96 | 88 | 155 | 156 |
Deposits & Other Assets | 153 | 156 | 145 | 140 | 127 |
Total Assets | 2,163 | 2,316 | 1,741 | 2,278 | 2,353 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 281 | 253 | 233 | 291 | 258 |
Current Portion Long-Term Debt | 9 | 8 | 6 | 5 | 5 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1,098 | 1,267 | 738 | 1,006 | 1,100 |
Total Current Liabilities | 1,387 | 1,527 | 977 | 1,301 | 1,362 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 27 | 30 | 32 | 35 | 36 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 73 | 70 | 70 | 75 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,487 | 1,628 | 1,080 | 1,406 | 1,473 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 4 | 4 | 4 | 4 | 4 |
Capital Surplus | 2,039 | 2,021 | 1,987 | 1,971 | 1,947 |
Retained Earnings | -1,364 | -1,333 | -1,327 | -1,096 | -1,065 |
Other Equity | -3 | -4 | -3 | -7 | -7 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 676 | 688 | 661 | 872 | 879 |
Total Liabilities & Shareholder's Equity | 2,163 | 2,316 | 1,741 | 2,278 | 2,353 |
Total Common Equity | 676 | 688 | 661 | 872 | 879 |
Shares Outstanding | 411.20 | 411.00 | 406.00 | 406.00 | 414.80 |
Book Value Per Share | 1.64 | 1.68 | 1.63 | 2.15 | 2.12 |